US
Hatch-Waxman Patent Litigation (Branded)
| Hatch-Waxman Patent Litigation (Branded) — Highly Recommended |
|---|
| Covington & Burling |
| Finnegan Henderson Farabow Garrett & Dunner |
| Fish & Richardson |
| Paul Hastings |
| Sidley Austin |
| Venable |
| Williams & Connolly |
| WilmerHale |
| Hatch-Waxman Patent Litigation (Branded) — Recommended |
|---|
| Arnold & Porter |
| Bartlit Beck |
| Dechert |
| Jones Day |
| Kirkland & Ellis |
| Latham & Watkins |
| Mayer Brown |
| O'Melveny & Myers |
| Quinn Emanuel Urquhart & Sullivan |
| Lawyer | Section | Practice Area | Location |
|---|---|---|---|
| Brody, Steve | Non-IP Litigation & Enforcement | Product Liability, White-Collar/Govt. Investigations | Washington, D.C. |
| Carter, Maggie | Non-IP Litigation & Enforcement | White-Collar/Govt. Investigations | Los Angeles |
| Goetz, Richard | Non-IP Litigation & Enforcement | Product Liability | Los Angeles |
| Kappos, John | Intellectual Property | General Patent Litigation | Newport Beach |
| Pensabene, Lisa | Intellectual Property | Patent Strategy & Management, General Patent Litigation, Hatch-Waxman Patent Litigation | New York City |
| Petrocelli, Daniel | Non-IP Litigation & Enforcement | Product Liability | Century City |
| Sayeed, Hassen | Intellectual Property | Hatch-Waxman Patent Litigation | New York City |
| Voelz, Scott | Non-IP Litigation & Enforcement | Product Liability | Los Angeles |
| , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} |
Intellectual Property
O'Melveny & Myers
O'Melveny & Myers is a recommended firm in the area of Hatch-Waxman litigation for branded pharmaceutical companies. The firm acts for a number of major entities, including AstraZeneca, Amgen subsidiary Onyx Therapeutics and ViiV Healthcare.
New York-based Lisa Pensabene is the 2020 Branded Hatch-Waxman Litigator of the Year for a significant year of trial work and repeated market praise. She recently led a trial team for Amgen subsidiary Onyx related to its Kyprolis drug. The District of Delaware ultimately found the client’s patents valid following novel challenges to compound and formulation claims covering its product. Pensabene currently serves as the firm’s life sciences IP litigation head.
John Kappos is another noteworthy litigator at the firm, bringing two decades of experience in law. He is currently acting for Agilent Technologies in a trade secrets suit brought against a competitor.
New to the stars list is Hassen Sayeed, who acted alongside Pensabene in the Onyx litigation. His technical credentials are bolstered by a medical degree.
Non-IP Litigation & Enforcement
In the life sciences area, O’Melveny & Myers continues to be significantly active in the product liability and class actions area, demonstrated by a year of notable trial work for top pharmaceutical and device manufacturers. Product liability and mass torts chair Steve Brody in part supports the firm’s reputation in the area, and recently garnered awards attention from LMG Life Sciences as a finalist for the Non-IP Trial Lawyer of the Year honor for 2020. Among his notable matters from the past year, Brody represented Johnson & Johnson and Janssen Pharmaceuticals in the first opioid products case in the United States to go to trial. The Oklahoma court ordered the client to pay 2.6% of the $17.7 billion claim, and the matter is now on appeal. Brody is also active as lead for Ethicon in multi-state Attorney General investigations related to pelvic mesh products. One of the related cases on appeal in California may raise novel arguments connected to First Amendment, due process and excessive fines issues.
Leading trial lawyers Daniel Petrocelli and Richard Goetz act alongside Brody and the O’Melveny team further assisting Johnson & Johnson in opioid matters, including a multidistrict litigation in Ohio and others cases throughout the country.